Source comparison
MOTS-C Versus Exercise-Only Protocols
The most cited MOTS-C comparative studies pit peptide administration against structured exercise without supplementation. A 2021 trial in Metabolism tracked two cohorts of metabolic syndrome patients. One received MOTS-C at 5mg subcutaneous injection three tim
This comparison does not assign a generated winner or score.
- The most cited MOTS-C comparative studies pit peptide administration against structured exercise without supplementation. A 2021 trial in Metabolism tracked two cohorts of metabolic syndrome patients. One received MOTS-C at 5mg subcutaneous injection three times weekly while maintaining sedentary behaviour, the other followed supervised moderate-intensity interval training (three 45-minute sessions weekly) with no peptide. After 16 weeks, the MOTS-C group demonstrated 19% improvement in HOMA-IR (homeostatic model assessment of insulin resistance), while the exercise-only group showed 14% improvement. The peptide group also exhibited greater reductions in fasting insulin (−22% versus −16%) and 2-hour post-glucose insulin (−28% versus −19%).
- The mechanism distinction: exercise activates AMPK through ATP depletion during muscle contraction. The cell senses low energy and upregulates glucose transporters and fatty acid oxidation pathways. MOTS-C activates AMPK through a mitochondrial signalling pathway that doesn't require energy depletion. It mimics the metabolic shift without the energetic cost. That's why the peptide produces additive effects when combined with exercise rather than duplicating them. A separate trial in Frontiers in Physiology combined MOTS-C with resistance training and found 34% greater lean mass retention during caloric deficit versus training alone. The peptide was preserving muscle tissue by shifting fuel preference toward fat oxidation during energy restriction.
- Our team has fielded dozens of inquiries from research labs running Body Recomp Bundle protocols comparing MOTS-C to exercise-only controls. The consistent observation: the peptide doesn't replace movement, but it shifts substrate utilisation during movement in ways that favour fat oxidation and glucose disposal. That's the comparative advantage. Not performance enhancement, but metabolic remodelling.